NPPA: Manufacturers of N-95 masks directed to maintain parity in prices for non-govt procurements to curb black marketing

Manufacturers, importers and suppliers of N-95 has been directed by the National Pharmaceutical Pricing Authority (NPPA) for maintaining parity in prices for non-government procurements for the purpose of making available the same at genuine prices to avoid black marketing.

The mobve by NPPA comes after the complaints related to the black marketing against the higher pricing of N-95 masks in the country.

An NPPA order stated that the “In the wake of the prevailing situation due to COVID-19, the government is striving to ensure uninterrupted supply of N-95 in adequate quantity of HCWs. For this government is procuring N-95 masks directly from the manufacturers, importers and suppliers at bulk rates and at ex-factory prices. However it has been noticed that other procurers (non-government entities) are getting N-95 masks at differential prices,”
An direction has also been issued to all the medical device industry associations like AiMeD, MTaI, CII, FICCI and PWMAI to follow the same.
As per Essential Commodities Act, hoarding and black marketing is an offence and punishable under the act and masks and santisers are now in the essential commodities act. As per guidance issued by union health ministry and World Health Organization (WHO) for management of COVID-19, medical masks are meant for use of frontline healthcare workers (HCWs).

In the light of COVID-19 pandemic, Disaster Management Act (DMA), 2005 was enacted by Union Health Ministry from March 13, 2020 in the country and directed all States/UTs to take steps to ensure sufficient availability of surgical and protective mask, hand sanitizers and gloves at prices not exceeding the maximum retail prices (MRP) printed on it.
Demand of PPE kits, N-95 mask have also been increased, thus, it has been ensured by the government to curb the black marketing.
The consumers are not aware about the price of these products and price printed by manufacturer in the current situation of COVID-19.

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A